Precision Medicine in a Patient With Multiple Myeloma Presenting With t(2;11) and CCND1 Overexpression

Key Points

• The aim is to explore precision medicine strategies in a patient with multiple myeloma exhibiting specific genetic alterations.
• Case report design focusing on genetic analyses and treatment response.
• Examination of the t(2;11) translocation and CCND1 overexpression.
• Assessment of tailored therapeutic interventions based on genetic findings.
• Patient exhibited notable response to gene-targeted therapies.
• Clinical outcomes reflected improvements in disease management.
• Genetic markers influenced therapeutic decisions leading to better patient care.